1. Current US Preventive Services Task Force (USPSTF) screening criteria for lung cancer excludes many at-risk individuals and has poor ...
1. Men with idiopathic pulmonary fibrosis (IPF) have a higher comorbidity burden, worse baseline lung function, and shorter survival, with ...
Why the Yang-Tobin Index Matters Determining the right time to extubate a critically ill patient remains one of the most ...
1. When compared with inhaled corticosteroids (ICS) plus long-acting β-agonists (LABA), dupilumab treatment was associated with an increased risk of ...
1. Midazolam significantly reduces respiratory variability, leading to a more uniform and less adaptable breathing pattern, which may increase risk ...
1. Implementing a structured POCUS protocol for inpatients with undifferentiated dyspnea was associated with a 30% reduction in length of ...
1. Higher peak expiratory flow was associated with a lower probability and lower risk of headache in middle-aged and older ...
1. GSK paid $500 million upfront for global development rights to Hengrui’s portfolio of up to 12 early-stage assets. 2. ...
Key Points: 1. First FDA-approved therapy for non-cystic fibrosis bronchiectasis; addresses a major unmet respiratory need. 2. Phase 3 data ...
1. In this randomized trial, among patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slowed the decline in the forced vital ...
